Fotemustine plus dacarbazine for malignant melanoma

Fotemustine plus dacarbazine for malignant melanoma - PubMed

119 patients with metastatic melanoma received fotemustine 100 mg/m2 on days 1 and 8 and dacarbazine 250 mg/m2 on days 15-18. After a 5-week rest, ...

Combination chemotherapy of dacarbazine and fotemustine in ...

Combination chemotherapy of dacarbazine and fotemustine in disseminated malignant melanoma. ... Antineoplastic Combined Chemotherapy Protocols / therapeutic use* ...

Fotemustine plus dacarbazine for malignant melanoma - European ...

119 patients with metastatic melanoma received fotemustine 100 mg/m2 on days 1 and 8 and dacarbazine 250 mg/m2 on days 15–18. After a 5-week rest, ...

Fotemustine plus dacarbazine for malignant melanoma

119 patients with metastatic melanoma received fotemustine 100 mg/m2 on days 1 and 8 and dacarbazine 250 mg/m2 on days 15–18. After a 5-week rest, fotemustine ...

Fotemustine plus dacarbazine for malignant melanoma

119 patients with metastatic melanoma received fotemustine 100 mg/m2 on days 1 and 8 and dacarbazine 250 mg/m2 on days 15–18. After a 5-week rest, ...

Fotemustine Plus Dacarbazine for Malignant Melanoma

Haematological toxicity was about 50% lower than that with fotemustine alone. Hence, this is an active outpatient regimen for metastatic melanoma, especially ...

Phase III randomized study of fotemustine and dacarbazine versus ...

... dacarbazine, and fotemustine plus interferon alpha in patients with advanced malignant melanoma. A multicenter phase II study of the Italian ...

Ipilimumab with fotemustine in metastatic melanoma - The Lancet

... of fotemustine and ipilimumab than with ipilimumab alone or combined with dacarbazine ... Ipilimumab plus dacarbazine for previously untreated metastatic melanoma.

Cisplatin, dacarbazine, and fotemustine plus interferon α in patients ...

Sixty-four consecutive patients with advanced melanoma were treated with a combination of fotemustine 100 mg/m2 intravenously (i.v.) on Day ...

Fotemustine Compared With Dacarbazine in Patients With ...

Melanoma. March 15, 2004. Share on. Fotemustine Compared With Dacarbazine in Patients With Disseminated Malignant Melanoma: A Phase III Study. Authors: M.F. ...

Fotemustine plus dacarbazine for malignant melanoma. | Semantic ...

Semantic Scholar extracted view of "Fotemustine plus dacarbazine for malignant melanoma." by M. Avril et al.

Combination chemotherapy of dacarbazine and fotemustine in ...

A total of 70 patients presenting with a disseminated malignant melanoma were entered into a multicentric study of combination chemotherapy using dacarbazi.

A phase II study of the sequential administration of dacarbazine and ...

This schedule of sequential dacarbazine and fotemustine has low activity against metastatic melanoma, and the response rate for cerebral metastases is not ...

Fotemustine, dacarbazine, vindesine combination chemotherapy in ...

Fotemustine and dacarbazine constitute the most active single chemotherapeutic agents in the treatment of melanoma. In this phase II study we evaluated the ...

Fotemustine Compared With Dacarbazine in Patients With ...

Malignant melanoma (MM) is an aggressive tumor, since it is responsible for 65% of skin cancer deaths [1]. The incidence of mela- noma has ...

Cisplatin, dacarbazine, and fotemustine plus interferon Î± in patients ...

Combination chemotherapy of dacarbazine and fotemustine in disseminated malignant melanoma. Ex- perience of the French Group. Cancer ...

Sequential administration of varying doses of dacarbazine and ...

Sixty patients with widely metastatic melanoma received DTIC at 400, 500 or 800 mg m-2 followed by fotemustine (100 mg m-1) at 4 h after DTIC ...

Impact of prior treatment with immune checkpoint inhibitors ... - Nature

... plus fotemustine combination on 86 advanced melanoma ... Ipilimumab plus dacarbazine for previously untreated metastatic melanoma.

Treatment of Metastatic Malignant Melanoma with Dacarbazine plus ...

Dacarbazine plus tamoxifen is more effective than dacarbazine alone, as indicated by both the response rate and the median survival.

Bevacizumab plus Fotemustine as First-line Treatment in Metastatic ...

... of bevacizumab plus fotemustine has clinical ... Fotemustine compared with dacarbazine in patients with disseminated malignant melanoma: a phase III study.